ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,572.07
-0.76%
US Tech 100
18,941.60
0.17%
다우존스 지수
41,433.48
-1.14%
Bitcoin
82,791.07
5.50%
Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Theratechnologies Inc (THTX)

  7. Theratechnologies Inc (THTX) 뉴스

THTX

Theratechnologies (THTX)

Theratechnologies Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:THTX
일자시간출처헤드라인심볼기업
2025/02/2622:32Edgar (US Regulatory)Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]NASDAQ:THTXTheratechnologies Inc
2025/02/2622:30Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:THTXTheratechnologies Inc
2025/02/2621:30GlobeNewswire Inc.Theratechnologies Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2024NASDAQ:THTXTheratechnologies Inc
2025/02/2206:37Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:THTXTheratechnologies Inc
2025/02/1501:12Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:THTXTheratechnologies Inc
2025/02/1500:51Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:THTXTheratechnologies Inc
2025/02/1421:30GlobeNewswire Inc.Theratechnologies to Announce Fourth Quarter and Full Year 2024 Financial Results and Provide Business UpdateNASDAQ:THTXTheratechnologies Inc
2025/02/1409:45GlobeNewswire Inc.Theratechnologies Resumes Distribution of EGRIFTA SV®NASDAQ:THTXTheratechnologies Inc
2025/01/1021:01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:THTXTheratechnologies Inc
2025/01/1007:05GlobeNewswire Inc.Theratechnologies Provides Update on EGRIFTA SV® SupplyNASDAQ:THTXTheratechnologies Inc
2024/12/2005:55Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:THTXTheratechnologies Inc
2024/12/1903:30GlobeNewswire Inc.Theratechnologies Announces Filing of FDA Prior Approval Supplement for EGRIFTA SV® Manufacturing EnvironmentNASDAQ:THTXTheratechnologies Inc
2024/12/1301:58Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:THTXTheratechnologies Inc
2024/12/1105:15GlobeNewswire Inc.Theratechnologies Receives March 2025 PDUFA Goal Date for Updated Tesamorelin F8 Formulation sBLANASDAQ:THTXTheratechnologies Inc
2024/12/1004:35Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:THTXTheratechnologies Inc
2024/12/0921:30GlobeNewswire Inc.Theratechnologies Announces Preliminary Tolerability and Efficacy Data from Phase 1b, Dose-Ranging Trial of Sudocetaxel Zendusortide in Patients with Advanced Ovarian CancerNASDAQ:THTXTheratechnologies Inc
2024/12/0600:43Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:THTXTheratechnologies Inc
2024/12/0501:44Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:THTXTheratechnologies Inc
2024/12/0422:53Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:THTXTheratechnologies Inc
2024/12/0421:30GlobeNewswire Inc.Theratechnologies Announces Exclusive Licensing Agreement with Ionis to Commercialize Olezarsen and Donidalorsen in CanadaNASDAQ:THTXTheratechnologies Inc
2024/12/0406:30GlobeNewswire Inc.Theratechnologies Announces Resumed Production of EGRIFTA SV®NASDAQ:THTXTheratechnologies Inc
2024/12/0300:20Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:THTXTheratechnologies Inc
2024/12/0221:30GlobeNewswire Inc.Theratechnologies Secures up to $75 Million in New Credit Facilities with TD Bank and Investissement QuébecNASDAQ:THTXTheratechnologies Inc
2024/11/2701:41Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:THTXTheratechnologies Inc
2024/11/2621:30GlobeNewswire Inc.Theratechnologies Submits Updated Tesamorelin F8 Formulation sBLA for FDA ReviewNASDAQ:THTXTheratechnologies Inc
2024/10/1803:00GlobeNewswire Inc.Theratechnologies IDWeek Presentations Highlight the Impact of Excess Visceral Abdominal Fat (EVAF) on Cardiovascular Disease (CVD) Risk in People with HIVNASDAQ:THTXTheratechnologies Inc
2024/10/1720:30GlobeNewswire Inc.Theratechnologies Unveils Study Design and Baseline Characteristics of PROMISE-US Trial of Ibalizumab in Heavily Treatment-Experienced People with HIV and Multidrug ResistanceNASDAQ:THTXTheratechnologies Inc
2024/10/1021:36Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:THTXTheratechnologies Inc
2024/10/1021:31Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:THTXTheratechnologies Inc
2024/10/1020:30GlobeNewswire Inc.Theratechnologies Reports Strong Financial Results and Announces Positive Net Income for Third Quarter 2024NASDAQ:THTXTheratechnologies Inc
 검색 관련기사 보기:NASDAQ:THTX

최근 히스토리

COIN
ETHUSD
Ethereum
NASDAQ
QQQ
Invesco QQQ Trust Series 1
NYSE
JPM
JP Morgan Chase
USI
USTECH100
US Tech 100
AMEX
XLF
Financial Select Sector
NYSE
XOM
Exxon Mobil
USOTC
DTEGY
Deutsche Telekom (QX)
NYSE
NKE
Nike
CCOM
US500
US 500
NYSE
VZ
Verizon Communications
NASDAQ
GOOGL
Alphabet
PM
XAUUSD
Gold vs US Dollar
CCOM
US100
US Tech 100
AMEX
XLV
Health Care Select Sector
USOTC
RHHBY
Roche (QX)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2025 ADVFN PLC - 모든 권리 보유

광고 제거

광고 없는 경험을 위해 가입하세요

광고 없음

지금 사용해 보세요

광고 유지